Corey M Anderson

US Patent:

8424235, Apr 23, 2013

Filed:

Jan 25, 2007

Appl. No.:

11/627055

Inventors:

Corey Anderson - Ramsey MN, US

International Classification:

A01K 85/01
A01K 97/04

US Classification:

43 4, 43 176, 43 4253

Abstract:

Methods and devices for recharging glow-in-the-dark fishing lures. Devices can include an internal cavity, an external opening into the cavity and a light source projecting into the cavity. Some cavities have an opaque, reflective wall and a light source projecting directly into the cavity. Other cavities have a translucent cavity wall and a light source shining in from outside of the cavity, through the cavity wall, and into the cavity. The light may be activated using a manual switch or an automatic switch which triggers upon detecting the passage of a lure into the cavity or the presence of a lure within the cavity. One such lure detector includes a weight sensitive electrical switch. Devices may resemble hand held mugs with handles or may be flange mounted into through-holes in boats decks.

US Patent:

20210047323, Feb 18, 2021

Filed:

Aug 13, 2020

Appl. No.:

16/992441

Inventors:

- Boston MA, US
Kevin J. Gagnon - Acton MA, US
Jicong Li - Cambridge MA, US
Jennifer Lu - San Diego CA, US
Ales Medek - Winchester MA, US
Muna Shrestha - Belmont MA, US
Michael Waldo - Grafton MA, US
Beili Zhang - San Diego CA, US
Carl L. Zwicker - Wakefield MA, US
Corey Don Anderson - Brighton MA, US
Jeremy J. Clemens - San Diego CA, US
Thomas Cleveland - San Marcos CA, US
Timothy Richard Coon - Carlsbad CA, US
Bryan Frieman - La Jolla CA, US
Peter Grootenhuis - Del Mar CA, US
Sara Sabina Hadida Ruah - La Jolla CA, US
Jason McCartney - Cardiff by the Sea CA, US
Mark Thomas Miller - Rancho Santa Fe CA, US
Prasuna Paraselli - San Diego CA, US
Fabrice Pierre - La Jolla CA, US
Sara E. Swift - San Diego CA, US
Jinglan Zhou - San Diego CA, US

International Classification:

C07D 471/08

Abstract:

Crystalline forms of Compound I:pharmaceutically acceptable salts thereof, and solvates and hydrates thereof are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.